PRECIGEN, INC. - Common Stock (PGEN)

Historical Holders from Q1 2016 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
PGEN on Nasdaq
Shares outstanding
332,525,463
Price per share
$4.18
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
111,297,177
Holdings value
$366,220,521
% of all portfolios
0%
Share change
+26,528,533
Value change
+$89,540,537
Average buys %
+0%
Average sells %
-0%
Number of holders
165
Price from insider filings
$4.18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PRECIGEN, INC. - Common Stock (PGEN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Patient Capital Management, LLC 14% $148,785,193 45,223,463 Patient Capital Management, LLC 31 Dec 2024
Miller William H III 9.2% $154,936,259 34,051,925 William H. Miller III Living Trust dated April 17, 2017 26 Jun 2025
As of 30 Sep 2025, PRECIGEN, INC. - Common Stock (PGEN) has 165 institutional shareholders filing 13F forms. They hold 111,297,177 shares of 332,525,463 outstanding shares (33%) .

Top 25 institutional shareholders own 30% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Patient Capital Management, LLC 8% 26,460,848 +63% 3.5% $87,056,189
TANG CAPITAL MANAGEMENT LLC 3.7% 12,400,000 1.6% $40,796,000
BlackRock, Inc. 3.7% 12,149,955 +9% 0% $39,973,352
VANGUARD GROUP INC 2.7% 8,942,285 -1.4% 0% $29,420,118
STATE STREET CORP 1.4% 4,489,827 +48% 0% $14,771,531
GEODE CAPITAL MANAGEMENT, LLC 1.2% 3,848,738 +2.7% 0% $12,665,203
IRIDIAN ASSET MANAGEMENT LLC/CT 1.1% 3,666,946 -14% 4.7% $12,064,252
Point72 Asset Management, L.P. 0.82% 2,741,066 0.02% $9,018,107
Occam Crest Management LP 0.81% 2,697,400 0% 6% $8,874,446
CITADEL ADVISORS LLC 0.81% 2,695,831 +756% 0.01% $8,869,284
BANK OF AMERICA CORP /DE/ 0.75% 2,505,992 +201% 0% $8,244,713
Parkman Healthcare Partners LLC 0.63% 2,101,715 +36% 0.76% $6,914,642
Driehaus Capital Management LLC 0.61% 2,042,510 0.05% $6,719,858
MORGAN STANLEY 0.6% 1,981,643 -2.9% 0% $6,519,606
NORTHERN TRUST CORP 0.41% 1,375,964 -2.2% 0% $4,526,922
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.38% 1,259,913 -0.85% 0% $4,145,114
Diametric Capital, LP 0.29% 974,228 +191% 1.2% $3,205,210
Schonfeld Strategic Advisors LLC 0.26% 856,593 -40% 0.02% $2,818,188
Boxer Capital Management, LLC 0.26% 850,000 0.89% $2,796,500
ADAGE CAPITAL PARTNERS GP, L.L.C. 0.25% 846,000 -92% 0% $2,783,340
Nuveen, LLC 0.24% 798,807 +61% 0% $2,628,075
Corient Private Wealth LLC 0.24% 797,571 +12% 0% $2,624,009
MILLENNIUM MANAGEMENT LLC 0.23% 779,558 +227% 0% $2,564,746
JPMORGAN CHASE & CO 0.23% 760,395 -2.4% 0% $2,501,699
GOLDMAN SACHS GROUP INC 0.22% 733,487 +45% 0% $2,413,172

Institutional Holders of PRECIGEN, INC. - Common Stock (PGEN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 51,920 $216,672 +$66,607 $4.18 3
2025 Q3 111,297,177 $366,220,521 +$89,540,537 $3.29 165
2025 Q2 82,070,744 $116,553,437 +$2,653,098 $1.42 146
2025 Q1 80,141,199 $119,307,433 +$7,804,791 $1.49 136
2024 Q4 75,814,328 $84,742,325 +$1,070,911 $1.12 129
2024 Q3 74,934,960 $70,966,755 +$13,973,288 $0.9471 124
2024 Q2 60,722,436 $95,930,295 -$1,317,827 $1.58 130
2024 Q1 61,436,467 $89,070,769 -$836,331 $1.45 128
2023 Q4 53,961 $72,308 -$6,842 $1.34 1
2023 Q3 60,326,152 $85,656,099 +$4,914,758 $1.42 132
2023 Q2 57,376,370 $65,964,203 -$3,637,529 $1.15 135
2023 Q1 61,451,330 $65,129,704 +$19,779,444 $1.06 153
2022 Q4 42,198,589 $64,132,069 -$61,573 $1.52 153
2022 Q3 123,770,197 $262,374,378 -$18,492,562 $2.12 146
2022 Q2 134,052,498 $179,630,618 -$10,336,598 $1.34 150
2022 Q1 141,915,462 $299,433,631 +$573,278 $2.11 154
2021 Q4 134,548,317 $499,032,547 +$13,706,546 $3.71 152
2021 Q3 138,094,507 $689,367,574 -$19,024,848 $4.99 159
2021 Q2 141,884,595 $925,068,614 +$582,061 $6.52 140
2021 Q1 134,470,969 $926,476,658 +$132,584,494 $6.89 149
2020 Q4 120,194,964 $1,225,950,827 -$21,695,614 $10.20 138
2020 Q3 116,380,054 $407,345,211 +$6,752,478 $3.50 140
2020 Q2 121,483,897 $606,112,480 -$28,494,596 $4.99 140
2020 Q1 121,131,645 $411,831,018 +$410,986,586 $3.40 127
2019 Q4 159,003 $915,000 +$636,004 $5.48 3
2019 Q3 42,862 $279,000 $0 $6.51 1
2019 Q2 42,862 $279,000 $0 $6.51 1
2019 Q1 42,862 $279,000 $0 $6.51 1
2016 Q2 0 $0 -$12,709 0
2016 Q1 375 $12,709 $0 $33.89 1